Skip to main content
. 2023 Jan 5;22(1):1–7. doi: 10.18502/cjn.v22i1.12610

Table 1.

Summary of the case scenarios

Case
No.
Case description Cognitive function Physical status MRI findings
1 36 year-old female, known case of MS, on GA Cognitive decline over 3 years Stable Stable
2 41 year-old man, borderline cognitive function at MS diagnosis two years ago, on fingolimod Severe cognitive decline in the last 6 months, other possible causes ruled out Stable New T2 lesions and severe cerebral atrophy
3 45 year-old female, known case of MS, on IFN-beta 1a for 11 years No previous cognitive evaluation, now shows impaired information processing speed (SDMT, PASAT: z score < -1.5) and delayed recall (CVLT-II delayed recall: z score < -1.5) Stable Cerebral atrophy
4 32 year-old female, diagnosed with MS one year ago, on GA (plans for pregnancy) Impaired information processing speed (SDMT: z score < -1.5), no change Stable Mild cortical atrophy at diagnosis, no change
5 24 year-old male student, recently diagnosed with MS, IFN-beta 1a started, comes for the second opinion Impaired information processing speed (SDMT, PASAT: z score < -1.5) (other causes ruled out) and delayed recall (CVLT-II delayed recall: z score < -1.5) Right-sided hemiparesthesia (recovery with IVMP) Brain MRI: 5 periventricular lesions (2 enhancing, 1 juxtacortical lesion)
Spine MRI: normal
6 38 year-old man, known case of MS for 3 years, on DMF Evaluation not performed previously, now shows impaired information processing speed (SDMT, PASAT: z score < -1.5) One mild non-disabling attack each year since then Brain MRI: 1 enhancing periventricular lesion, otherwise stable
Spine MRI: stable

MS: Multiple Sclerosis; GA: Glatiramer acetate; MRI: Magnetic resonance imaging; SDMT: Symbol Digit Modalities Test; PASAT: Paced Auditory Serial Addition Test; CVLT-II: California Verbal Learning Test® Second Edition; IFN-beta: Interferon-β; DMF: Dimethyl fumarate; IVMP: Intravenous methylprednisolone